Type II collagen peptides for measuring cartilage degradation

Abstract

This paper describes two new immunoassays for a peptide of the triple helix of type II collagen (Coll 2‐1) and its nitrated form (Coll 2‐1 NO₂). In healthy subjects aged between 20 and 65 years old, Coll 2‐1 and Coll 2‐1 NO₂ levels in serum were in means 125.13±3.71 and 0.16±0.08 nmol/l, respectively. These levels did not significantly vary with age. However, up to 45 years of age, Coll 2‐1 NO₂ levels in women were significantly higher than in men. In patients with knee osteoarthritis (OA), Coll 2‐1 in serum was found to be elevated compared to healthy controls (267.45±26.42 nmol/l vs 126.78±6.61 nmol/l). Further, we have demonstrated that an increase of the urinary levels of Coll 2‐1 or Coll 2‐1 NO₂ over 1 year was predictive of joint space narrowing progression in OA patients. In conclusion, these preliminary results indicate that Coll 2‐1 could be a predictive marker of knee OA progression.